John Fuller - Publications, H-index & Citations

Identification of Brain-Penetrant ATP-Competitive mTOR Inhibitors for CNS Syndromes

IF10.2

2023-10-23

OAAI

Elliott, Jackie; Sloan, Gordon; Stevens, Lynda; Selvarajah, Dinesh; Cruccu, Giorgio; Gandhi, Rajiv A.; Kempler, Peter; Fuller, John H.; Chaturvedi, Nishi; Tesfaye, Solomon

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2023-07-03

PREAI

Bonazzi, Simone; Gray, Audrey; Thomsen, Noel M.; Biag, Jonathan; Labbe-Giguere, Nancy; Keaney, Erin P.; Malik, Hasnain A.; Sun, Yingchuan; Nunez, Jill; Karki, Rajeshri G.; Knapp, Mark; Elling, Robert; Fuller, John; Pardee, Gwynn; Craig, Lucas; Capre, Ketthsy; Salas, Sarah; Gorde, Aakruti; Liang, Guiqing; Lubicka, Danuta; McTighe, Stephanie M.; Goold, Carleton; Liu, Shanming; Deng, Lin; Hong, Jin; Fekete, Alexander; Stadelmann, Pascal; Frieauff, Wilfried; Elhajouji, Azeddine; Bauer, Daniel; Lerchner, Andreas; Radetich, Branko; Furet, Pascal; Piizzi, Grazia; Burdette, Doug; Wilson, Christopher J.; Peukert, Stefan; Hamann, Lawrence G.; Murphy, Leon O.; Curtis, Daniel

Circulating matrix metalloproteinases are associated with arterial stiffness in patients with type 1 diabetes: pooled analysis of three cohort studies

MicroRNA-126 and micro-/macrovascular complications of type 1 diabetes in the EURODIAB Prospective Complications Study

IF10.6

2017-10-25

OAAI

Peeters, Stijn A.; Engelen, Lian; Buijs, Jacqueline; Chaturvedi, Nish; Fuller, John H.; Jorsal, Anders; Parving, Hans-Henrik; Tarnow, Lise; Theilade, Simone; Rossing, Peter; Schalkwijk, Casper G.; Stehouwer, Coen D. A.

ACTA DIABETOLOGICA

IF2.9

2016-10-01

OAAI

Barutta, Federica; Bruno, Graziella; Matullo, Giuseppe; Chaturvedi, Nish; Grimaldi, Serena; Schalkwijk, Casper; Stehouwer, Coen D.; Fuller, John H.; Gruden, Gabriella

Effect of atorvastatin on glycaemia progression in patients with diabetes: an analysis from the Collaborative Atorvastatin in Diabetes Trial (CARDS)

Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications Study (vol 14, 31, 2015)

IF10.2

2015-11-17

OAAI

Livingstone, Shona J.; Looker, Helen C.; Akbar, Tahira; Betteridge, D. John; Durrington, Paul N.; Hitman, Graham A.; Neil, H. Andrew W.; Fuller, John H.; Colhoun, Helen M.

Low 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 levels are independently associated with macroalbuminuria, but not with retinopathy and macrovascular disease in type 1 diabetes: the EURODIAB prospective complications study

IF10.6

2015-09-28

OAAI

Peeters, Stijn A.; Engelen, Lian; Buijs, Jacqueline; Chaturvedi, Nish; Fuller, John H.; Schalkwijk, Casper G.; Stehouwer, Coen D.

Plasma levels of matrix metalloproteinase-2,-3,-10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications Study

IF10.6

2015-05-30

OAAI

Engelen, Lian; Schalkwijk, Casper G.; Eussen, Simone J. P. M.; Scheijen, Jean L. J. M.; Soedamah-Muthu, Sabita S.; Chaturvedi, Nish; Fuller, John H.; Stehouwer, Coen D. A.

Predicting major outcomes in type 1 diabetes: a model development and validation study 预测1型糖尿病的主要结局: 模型开发和验证研究

IF10.6

2015-03-10

OAAI

Peeters, Stijn A.; Engelen, Lian; Buijs, Jacqueline; Chaturvedi, Nish; Fuller, John H.; Schalkwijk, Casper G.; Stehouwer, Coen D.

Higher dietary salt intake is associated with microalbuminuria, but not with retinopathy in individuals with type 1 diabetes: the EURODIAB Prospective Complications Study

IF10.2

2014-09-04

OAAI

Soedamah-Muthu, Sabita S.; Vergouwe, Yvonne; Costacou, Tina; Miller, Rachel G.; Zgibor, Janice; Chaturvedi, Nish; Snell-Bergeon, Janet K.; Maahs, David M.; Rewers, Marian; Forsblom, Carol; Harjutsalo, Valma; Groop, Per-Henrik; Fuller, John H.; Moons, Karel G. M.; Orchard, Trevor J.

LADA and CARDS: A Prospective Study of Clinical Outcome in Established Adult-Onset Autoimmune Diabetes

IF10.2

2014-08-30

OAAI

Engelen, Lian; Soedamah-Muthu, Sabita S.; Geleijnse, Johanna M.; Toeller, Monika; Chaturvedi, Nish; Fuller, John H.; Schalkwijk, Casper G.; Stehouwer, Coen D. A.

Glycemic Control and All-Cause Mortality Risk in Type 1 Diabetes Patients: The EURODIAB Prospective Complications Study

IF16.6

2014-05-10

OAAI

Hawa, Mohammed Iqbal; Buchan, Ana Paula; Ola, Thomas; Wun, Chuan Chuan; DeMicco, David A.; Bao, Weihang; Betteridge, D. John; Durrington, Paul N.; Fuller, John H.; Neil, H. Andrew W.; Colhoun, Helen; Leslie, Richard David; Hitman, Graham A.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

IF5.1

2014-03-01

OAAI

Schoenaker, Danielle A. J. M.; Simon, Dominique; Chaturvedi, Nish; Fuller, John H.; Soedamah-Muthu, Sabita S.

Protein intake in relation to risk of hypertension and microalbuminuria in patients with type 1 diabetes: the EURODIAB Prospective Complications Study

JOURNAL OF HYPERTENSION

IF4.1

2013-06-01

PREAI

Altorf-van der Kuil, Wieke; Engberink, Marielle F.; IJpma, Irene; Verberne, Lisa D. M.; Toeller, Monika; Chaturvedi, Nish; Fuller, John H.; Soedamah-Muthu, Sabita S.

NH2-Terminal Probrain Natriuretic Peptide Is Associated With Diabetes Complications in the EURODIAB Prospective Complications Study

Severe Hypoglycemia and Cardiovascular Disease Incidence in Type 1 Diabetes The EURODIAB Prospective Complications Study

IF16.6

2012-08-14

OAAI

Gruden, Gabriella; Barutta, Federica; Chaturvedi, Nish; Schalkwijk, Casper; Stehouwer, Coen D.; Pinach, Silvia; Manzo, Maria; Loiacono, Maria; Tricarico, Marinella; Mengozzi, Giulio; Witte, Daniel R.; Fuller, John H.; Perin, Paolo Cavallo; Bruno, Graziella

Genome-wide association study of genetic determinants of LDL-c response to atorvastatin therapy: importance of Lp(a)Ldl-c对阿托伐他汀治疗反应的遗传决定因素的全基因组关联研究: Lp(a) 的重要性

IF16.6

2012-06-12

OAAI

Gruden, Gabriella; Barutta, Federica; Chaturvedi, Nish; Schalkwijk, Casper; Stehouwer, Coen D.; Witte, Daniel R.; Fuller, John H.; Perin, Paolo Cavallo; Bruno, Graziella

JOURNAL OF LIPID RESEARCH

IF4.1

2012-05-01

108

OAAI

Deshmukh, Harshal A.; Colhoun, Helen M.; Johnson, Toby; McKeigue, Paul M.; Betteridge, D. John; Durrington, Paul N.; Fuller, John H.; Livingstone, Shona; Charlton-Menys, Valentine; Neil, Andrew; Poulter, Neil; Sever, Peter; Shields, Denis C.; Stanton, Alice V.; Chatterjee, Aurobindo; Hyde, Craig; Calle, Roberto A.; DeMicco, David A.; Trompet, Stella; Postmus, Iris; Ford, Ian; Jukema, J. Wouter; Caulfield, Mark; Hitman, Graham A.

Serum high-mobility group box-1 levels are positively associated with micro- and macroalbuminuria but not with cardiovascular disease in type 1 diabetes: the EURODIAB Prospective Complications Study

EUROPEAN JOURNAL OF ENDOCRINOLOGY

IF5.2

2012-02-01

PREAI

Nin, Johanna W. M.; Ferreira, Isabel; Schalkwijk, Casper G.; Prins, Martin H.; Chaturvedi, Nish; Fuller, John H.; Stehouwer, Coen D. A.

QTc Interval Prolongation Is Independently Associated With Severe Hypoglycemic Attacks in Type 1 Diabetes From the EURODIAB IDDM Complications Study